In the pIns-c-MycERTAM/RIP-Bcl-xL-RIP models, transgenic stimulation and inhibition of the c-Myc oncogene and the apoptosis inhibitor Bcl-xL, respectively, promote the formation of an aggressive insulinoma subtype [50]. Here, BCL2L1 is linked to pancreatic insulinoma.